Single DMT Dose Provides Lasting Relief from Depression

Summary: While psychedelic research often focuses on hours-long “trips” with psilocybin or LSD, a landmark Phase IIa trial has proven that a much shorter experience can be just as potent.…

Antidepressants May Safeguard Against Preterm Birth Risks

Summary: An extensive population-based study involving over 1.2 million births has clarified the complex impact of SSRI antidepressant use during pregnancy. The research found that while SSRIs are associated with…

Anti-Inflammatory Treatments Show Promise for Depression

Summary: A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who also have chronic, low-grade inflammation. By reviewing randomized controlled trials…

CBD Can Reduce Aggression in Dogs

Summary: A massive multi-year analysis of tens of thousands of dogs reveals that CBD use is becoming increasingly common among aging companion animals. While dogs given CBD initially showed higher…

Psychedelic ‘Ego Death’ Tied to a Collapse in Alpha Brain Waves

Summary: A new study using DMT as a scientific tool reveals how psychedelics alter the brain’s alpha-wave dynamics and weaken our sense of self. The researchers found that DMT pushes…

New Drug Exposes Hidden Subtypes of Psychosis

Summary: A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years.…

Antibiotic Doxycycline May Cut Schizophrenia Risk

Summary: A large population-based study suggests that doxycycline, a common antibiotic, may reduce the risk of schizophrenia when prescribed to adolescents receiving mental health care. Researchers analyzed data from more…

Common Antidepressant Eases Core Symptoms Within Two Weeks

Summary: A new analysis of the PANDA clinical trial reveals that sertraline, one of the most prescribed antidepressants, improves key emotional symptoms of depression—such as sadness, self-loathing, and suicidal thoughts—within…

Ketamine Fails to Outperform Placebo in Major Depression Trial

Summary: A large randomized and blinded clinical trial has found no additional benefit of repeated ketamine infusions over standard inpatient care for treating major depression. The study compared ketamine with…

EEG Test May Reveal Who Loses Libido on Antidepressants

Summary: A new study reveals that serotonin levels in the brain, measured using a simple EEG-based test, can predict who will experience sexual side effects from SSRI antidepressants. Researchers found…